List of Contributions

Hopewell, NJ – June 23, 2025 – ProBio Inc., a global contract development and manufacturing organization (CDMO) specializing in cell and gene therapy, today announced the opening of its flagship Cell and Gene Therapy Center of Excellence at the Princeton West Innovation Campus in Hopewell, New Jersey. ...

Explore the Hub As of 2025, the bispecific antibody (BsAb) market exceeds USD 10 billion, fueled by multiple FDA approvals and 300+ clinical candidates. BsAbs now go beyond T-cell engagers to include NK cell engagers, dual checkpoint inhibitors, receptor clustering agents, and tumor-targeted cytokines, ...

As biomedicine advances and market demands evolve, high-concentration protein formulations (HCPF) are gaining increasing prominence in the biopharmaceutical industry. However, developing these formulations presents several challenges. Drawing on extensive experience in biologics development, ProBio has ...

Join us on April 22nd for an exclusive webinar on #CGT development! Gain expert knowledge on optimizing #plasmid and #LVV production timelines, ensuring regulatory compliance, and navigating IND and BLA applications across global agencies. Don't miss this opportunity to stay ahead in the evolving CGT ...